- Investing Ideas
- Indian Pharmaceuticals & Biotech High ROE Growth Engines
Indian Pharmaceuticals & Biotech High ROE Growth Engines
Results
7
7 companies
Abbott India
Market Cap: ₹591.7b
Operates as a pharmaceutical company in India.
500488
₹27,845.85
7D
-0.2%
1Y
-16.3%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹448.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,647.45
7D
0.2%
1Y
-6.8%
Ajanta Pharma
Market Cap: ₹440.2b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,525.10
7D
5.5%
1Y
33.7%
CORONA Remedies
Market Cap: ₹132.1b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,159.70
7D
4.3%
1Y
n/a
Sanofi India
Market Cap: ₹78.1b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,391.80
7D
0.9%
1Y
-37.5%
Sat Kartar Life
Market Cap: ₹2.0b
An ayurvedic healthcare company, provides ayurvedic products in India.
SATKARTAR
₹125.30
7D
-1.2%
1Y
-30.4%
Colinz Laboratories
Market Cap: ₹196.5m
Manufactures, markets, and trades in pharmaceutical formulations in India.
531210
₹78.00
7D
-6.0%
1Y
72.3%